105 related articles for article (PubMed ID: 8321861)
1. Structure of 3-acetyl-5-fluorouracil (5-FU): implication for its rearrangements during hydrolysis and upon heating.
Beall HD; Prankerd RJ; Todaro LJ; Sloan KB
Pharm Res; 1993 Jun; 10(6):905-12. PubMed ID: 8321861
[TBL] [Abstract][Full Text] [Related]
2. Hydrolytic pathway of 5-fluorouracil in aqueous solutions for clinical use.
Legay R; Massou S; Azéma J; Martino R; Malet-Martino M
J Pharm Biomed Anal; 2014 Sep; 98():446-62. PubMed ID: 25038499
[TBL] [Abstract][Full Text] [Related]
3. Fluorouracil prodrugs for the treatment of proliferative vitreoretinopathy: formulation in silicone oil and in vitro release of fluorouracil.
Jolimaître P; Malet-Martino M; Martino R
Int J Pharm; 2003 Jun; 259(1-2):181-92. PubMed ID: 12787646
[TBL] [Abstract][Full Text] [Related]
4. 19F-NMR, 1H-NMR, and fluorescence studies of interaction between 5-fluorouracil and polyglycerol dendrimers.
Lee H; Ooya T
J Phys Chem B; 2012 Oct; 116(40):12263-7. PubMed ID: 22978446
[TBL] [Abstract][Full Text] [Related]
5. [Supra-molecular assembly and magnetic targeted slow-release effect of "dextran-magnetic layered double hydroxide-fluorouracil" drug delivery system].
Gou GJ; Liu YH; Sun Y; Huang J; Xue B; Dong LE
Yao Xue Xue Bao; 2011 Nov; 46(11):1390-8. PubMed ID: 22260036
[TBL] [Abstract][Full Text] [Related]
6. [Synthesis and properties of 5-fluorouracil derivatives].
Semakov AV; Blinkov AA; Gaenko GP; Vostrova AG; Molotkovskiĭ IuG
Bioorg Khim; 2013; 39(3):338-45. PubMed ID: 24397032
[TBL] [Abstract][Full Text] [Related]
7. The polycondensing temperature rather than time determines the degradation and drug release of poly(glycerol-sebacate) doped with 5-fluorouracil.
Sun ZJ; Sun CW; Sun B; Lu XL; Dong DL
J Biomater Sci Polym Ed; 2012; 23(6):833-41. PubMed ID: 21418749
[TBL] [Abstract][Full Text] [Related]
8. A study of purified montmorillonite intercalated with 5-fluorouracil as drug carrier.
Lin FH; Lee YH; Jian CH; Wong JM; Shieh MJ; Wang CY
Biomaterials; 2002 May; 23(9):1981-7. PubMed ID: 11996039
[TBL] [Abstract][Full Text] [Related]
9. 5-Fluorouracil derivatives from the sponge Phakellia fusca.
Xu XH; Yao GM; Li YM; Lu JH; Lin CJ; Wang X; Kong CH
J Nat Prod; 2003 Feb; 66(2):285-8. PubMed ID: 12608868
[TBL] [Abstract][Full Text] [Related]
10. [Synthesis of 5-fluorouracil derivatives containing alkanoic acid].
Xu LH; Weng LL; Zheng H
Sichuan Da Xue Xue Bao Yi Xue Ban; 2006 Jul; 37(4):644-6. PubMed ID: 16909623
[TBL] [Abstract][Full Text] [Related]
11. Research on 5-fluorouracil as a drug carrier materials with its in vitro release properties on organic modified magadiite.
Ge M; Tang W; Du M; Liang G; Hu G; Jahangir Alam SM
Eur J Pharm Sci; 2019 Mar; 130():44-53. PubMed ID: 30660800
[TBL] [Abstract][Full Text] [Related]
12. Metabolites of 5-fluorouracil in plasma and urine, as monitored by 19F nuclear magnetic resonance spectroscopy, for patients receiving chemotherapy with or without methotrexate pretreatment.
Hull WE; Port RE; Herrmann R; Britsch B; Kunz W
Cancer Res; 1988 Mar; 48(6):1680-8. PubMed ID: 3125967
[TBL] [Abstract][Full Text] [Related]
13. Synthesis and properties of 2-acetylthiamin pyrophosphate: an enzymatic reaction intermediate.
Gruys KJ; Halkides CJ; Frey PA
Biochemistry; 1987 Dec; 26(24):7575-85. PubMed ID: 2827756
[TBL] [Abstract][Full Text] [Related]
14. Improved chemical syntheses of 5,6-dihydro-5-fluorouracil.
LaFrate AL; Katzenellenbogen JA
J Org Chem; 2007 Oct; 72(22):8573-6. PubMed ID: 17900141
[TBL] [Abstract][Full Text] [Related]
15. Synthesis and properties of N-nicotinoyl-2-(5-fluorouracil-1-yl)-D,L-glycine ester as a prodrug of 5-fluorouracil for rectal administration.
Yang YW; Lee JS; Kim I; Jung YJ; Kim YM
Eur J Pharm Biopharm; 2007 May; 66(2):260-7. PubMed ID: 17182232
[TBL] [Abstract][Full Text] [Related]
16. Multicomponent 5-fluorouracil loaded PAMAM stabilized-silver nanocomposites synergistically induce apoptosis in human cancer cells.
Matai I; Sachdev A; Gopinath P
Biomater Sci; 2015 Mar; 3(3):457-68. PubMed ID: 26222289
[TBL] [Abstract][Full Text] [Related]
17. Cocrystal of 5-Fluorouracil: Characterization and Evaluation of Biopharmaceutical Parameters.
Gautam MK; Besan M; Pandit D; Mandal S; Chadha R
AAPS PharmSciTech; 2019 Mar; 20(4):149. PubMed ID: 30903402
[TBL] [Abstract][Full Text] [Related]
18. Synthesis of Biotin-Modified Galactosylated Chitosan Nanoparticles and Their Characteristics in Vitro and in Vivo.
Cheng M; Ma D; Zhi K; Liu B; Zhu W
Cell Physiol Biochem; 2018; 50(2):569-584. PubMed ID: 30308481
[TBL] [Abstract][Full Text] [Related]
19. Epidoxoform: a hydrolytically more stable anthracycline-formaldehyde conjugate toxic to resistant tumor cells.
Taatjes DJ; Fenick DJ; Koch TH
J Med Chem; 1998 Apr; 41(8):1306-14. PubMed ID: 9548820
[TBL] [Abstract][Full Text] [Related]
20. 5-Fluorouracil delivery from metal-ion mediated molecularly imprinted cryogel discs.
Çetin K; Denizli A
Colloids Surf B Biointerfaces; 2015 Feb; 126():401-6. PubMed ID: 25601094
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
